Marianna Fontana

This discussion features Marianna Fontana, a Professor of Cardiology and Consultant at the National Amyloidosis Center, who shares insights on cutting-edge drug treatments for cardiac amyloidosis. Carlos Aguiar reviews recent studies, notably the evolving criteria for ICD use in primary prevention, advocating for personalized approaches in cardiac care. The conversation dives into new therapies, including stabilizers and gene silencers, as well as surprising myths about neckties in healthcare. Tune in for a blend of serious research and lighthearted myth-busting!